Abstract
Rationale
Hyperactivity, impulsivity, and inattention are major symptoms occurring in attention-deficit/hyperactivity disorder. This disorder is highly heritable, multifactorial, polygenic, and associated primarily with dysfunctions of dopaminergic, noradrenergic, and serotonergic systems.
Objectives
The present study tested the possible association of the catechol-O-methyltransferase (COMT) Val108/158Met (rs4680) polymorphism with hyperactive–impulsive and inattentive symptoms in male youth.
Method
Polymorphism COMT Val108/158Met was analyzed in 807 male unrelated Caucasian young subjects: 231 healthy controls, 195 subjects with moderate hyperactive symptoms and 254 subjects with moderate inattentive symptoms, 111 subjects with severe hyperactive symptoms and 90 subjects with severe inattentive symptoms, all evaluated using Swanson, Nolan, and Pelham Questionnaire IV criteria.
Results
The frequency of the COMT genotypes, alleles, and the homozygous Met/Met genotype versus Val carriers (χ 2 test with standardized residuals) differed significantly between subjects without and subjects with hyperactive–impulsive and inattentive symptoms. In addition, significantly higher hyperactive–impulsive and inattentive scores were found in subjects with the Met/Met genotype compared to carriers of other COMT genotypes. These significant results were due to the more frequent occurrence of Met/Met genotype or the Met allele in subjects with moderate and severe hyperactive–impulsive and inattentive symptoms compared to matched controls.
Conclusion
These results suggest that the Met/Met genotype or the Met allele of the COMT Val108/158Met, contributing to higher dopaminergic activity, are significantly overrepresented in subjects with moderate or severe hyperactive–impulsive and inattentive symptoms, and that this polymorphism is significantly associated with hyperactive–impulsive and inattentive symptoms in young boys and adolescents.
Similar content being viewed by others
References
Albaugh MD, Harder VS, Althoff RR, Rettew DC, Ehli EA, Lengyel-Nelson T, Davies GE, Ayer L, Sulman J et al (2010) COMT Val158Met genotype as a risk factor for problem behaviors in youth. J Am Acad Child Adolesc Psychiatry 49:841–849
Antshel KM, Hargrave TM, Simonescu M, Kaul P, Hendricks K, Faraone SV (2011) Advances in understanding and treating ADHD. BMC Med 9:72
APA (1994) Diagnostic and statistical manual of mental disorders IV edition. American Psychiatric, Washington
Asherson P (2005) Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Rev Neurother 5:525–539
Bellgrove MA, Domschke K, Hawi Z, Kirley A, Mullins C, Robertson IH, Gill M (2005) The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD. Exp Brain Res 163:352–360
Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehman BK, Doyle A (1993) Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 150:1792–1798
Biederman J, Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet 366:237–248
Biederman J, Kim JW, Doyle AE, Mick E, Fagerness J, Smoller JW, Faraone SV (2008) Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study. Am J Med Genet B Neuropsychiatr Genet 147B:1511–1518
Caspi A, Langley K, Milne B, Moffitt TE, O'Donovan M, Owen MJ, Polo Tomas M, Poulton R, Rutter M et al (2008) A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 65:203–210
Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM et al (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807–821
Daniel WW (1990) Applied nonparametric statistics. PWS Kent Publishing Company, Boston
DeYoung CG, Getchell M, Koposov RA, Yrigollen CM, Haeffel GJ, af Klinteberg B, Oreland L, Ruchkin VV, Pakstis AJ (2010) Variation in the catechol-O-methyltransferase Val 158 Met polymorphism associated with conduct disorder and ADHD symptoms, among adolescent male delinquents. Psychiatr Genet 20:20–24
Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98:6917–6922
Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313–1323
Field AP, Miles J, Field F (2012) Discovering statistics using R. SAGE Publications, Ltd., London
Franke B, Neale BM, Faraone SV (2009) Genome-wide association studies in ADHD. Hum Genet 126:13–50
Fritz CO, Morris PE, Richler JJ (2012) Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen 141:2–18
Gizer IR, Ficks C, Waldman ID (2009) Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 126:51–90
Halleland H, Lundervold AJ, Halmoy A, Haavik J, Johansson S (2009) Association between catechol O-methyltransferase [COMT] haplotypes and severity of hyperactivity symptoms in adults. Am J Med Genet B 150B:403–410
Kiive E, Kurrikoff T, Maestu J, Harro J (2010) Effect of alpha2A-adrenoceptor C-1291G genotype and maltreatment on hyperactivity and inattention in adolescents. Prog Neuropsychopharmacol Biol Psychiatry 34:219–224
Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243–250
Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 100:6186–6191
Matthews N, Vance A, Cummins TD, Wagner J, Connolly A, Yamada J, Lockhart PJ, Panwar A, Wallace RH et al (2012) The COMT Val158 allele is associated with impaired delayed-match-to-sample performance in ADHD. Behav Brain Funct 8:25
Merwood A, Greven CU, Price TS, Rijsdijk F, Kuntsi J, McLoughlin G, Larsson H, Asherson PJ (2013) Different heritabilities but shared etiological influences for parent, teacher and self-ratings of ADHD symptoms: an adolescent twin study. Psychol Med:1–12
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Monuteaux MC, Biederman J, Doyle AE, Mick E, Faraone SV (2009) Genetic risk for conduct disorder symptom subtypes in an ADHD sample: specificity to aggressive symptoms. J Am Acad Child Adolesc Psychiatry 48:757–764
Nagel IE, Chicherio C, Li SC, von Oertzen T, Sander T, Villringer A, Heekeren HR, Backman L, Lindenberger U (2008) Human aging magnifies genetic effects on executive functioning and working memory. Front Hum Neurosci 2:1
Nemoda Z, Szekely A, Sasvari-Szekely M (2011) Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. Neurosci Biobehav R 35:1665–1686
Paloyelis Y, Asherson P, Mehta MA, Faraone SV, Kuntsi J (2010) DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls. Neuropsychopharmacology 35:2414–2426
Pivac N, Knezevic A, Gornik O, Pucic M, Igl W, Peeters H, Crepel A, Steyaert J, Novokmet M et al (2011) Human plasma glycome in attention-deficit hyperactivity disorder and autism spectrum disorders. Mol Cell Proteomics 10(M110):004200
Qian QJ, Liu J, Wang YF, Yang L, Guan LL, Faraone SV (2009) Attention deficit hyperactivity disorder comorbid oppositional defiant disorder and its predominately inattentive type: evidence for an association with COMT but not MAOA in a Chinese sample. Behav Brain Funct 5:8
Reuter M, Kirsch P, Hennig J (2006) Inferring candidate genes for attention deficit hyperactivity disorder (ADHD) assessed by the World Health Organization Adult ADHD Self-Report Scale (ASRS). J Neural Transm 113:929–938
Robbins TW (2005) Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol 493:140–146
Sengupta SM, Grizenko N, Schmitz N, Schwartz G, Ben Amor L, Bellingham J, de Guzman R, Polotskaia A, Ter Stepanian M et al (2006) COMT Val108/158Met gene variant, birth weight, and conduct disorder in children with ADHD. J Am Acad Child Adolesc Psychiatry 45:1363–1369
Sharp SI, McQuillin A, Gurling HM (2009) Genetics of attention-deficit hyperactivity disorder (ADHD). Neuropharmacology 57:590–600
Spatz C (2011) Basic statistics: tales of distributions. Wadsworth, Belmont
Swanson JM (1992) School-based assessments and interventions for ADD students. KC Publishing, Irvine
Thapar A, Langley K, Fowler T, Rice F, Turic D, Whittinger N, Aggleton J, Van den Bree M, Owen M et al (2005) Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 62:1275–1278
Tomson K, Merenäkk L, Loit HM, Mäestu J, Harro J (2011) The relationship between serotonin transporter gene promoter polymorphism and serum lipid levels at young age in a longitudinal population-representative study. Prog Neuropsychopharmacol Biol Psychiat 35:1857–1862
Wahlstrom D, White T, Luciana M (2010) Neurobehavioral evidence for changes in dopamine system activity during adolescence. Neurosci Biobehav R 34:631–648
Wallis D (2010) The search for biomarkers for attention deficit/hyperactivity disorder. Drug News Perspect 23:438–449
Witte AV, Jansen S, Schirmacher A, Young P, Floel A (2010) COMT Val158Met polymorphism modulates cognitive effects of dietary intervention. Front Aging Neurosci 2:146
Acknowledgments
The authors are grateful to all patients and controls for their participation in the study. This study was supported by the Croatian Ministry of Science, Education and Sport, grant numbers 098-0982522-2455, 098-0982522-2457, the Estonian Science Foundation (no. 8607), the Estonian Ministry of Education and Science (no. 0180027), and the European Social Fund (Estonian Primus grant no. 3–8.2/60).
Conflict of interest
Authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Matea Nikolac Perkovic and Evelyn Kiive equally contributed to this work.
Rights and permissions
About this article
Cite this article
Nikolac Perkovic, M., Kiive, E., Nedic Erjavec, G. et al. The association between the catechol-O-methyltransferase Val108/158Met polymorphism and hyperactive–impulsive and inattentive symptoms in youth. Psychopharmacology 230, 69–76 (2013). https://doi.org/10.1007/s00213-013-3138-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-013-3138-1